Induction of a protection against S. mansoni with a MAP containing epitopes of Sm37-GAPDH and Sm10-DLC. Effect of coadsorbtion with GM-CSF on alum

Vaccine

Volumn 18, Issue 19, 2000, Pages 2033-2038

  Argiro, Laurent ^a   Henri, Sandrine ^a   Dessein, Hélia ^a   Kouriba, Bourema ^a   Dessein, Alain J ^a   Bourgois, Alain ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Cytokine; MAP; Schistosomiasis; Vaccination

Indexed keywords

ALUMINUM HYDROXIDE; ANTIGEN; FREUND ADJUVANT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT; SCHISTOSOMA VACCINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ALUM COMPOUNDS; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, HELMINTH; B-LYMPHOCYTES; DYNEIN ATPASE; EPITOPES; FEMALE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSORBENT TECHNIQUES; MICE; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 0033999911     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00523-X     Document Type: Article

References (20)

1. Bergquist N.R. Controlling schistosomiasis by vaccination: a realistic option? Parasitol. Today. 5:1995;191-194.
2. Goudot-Crozel V., Caillol D., Djabali M., Dessein A.J. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kDa glyceraldehyde-3-phosphate dehydrogenase. J. Exp. Med. 170:1989;2063-2080.
3. Kohlstädt S., Couisinier-Paris P., Bourgois A., Bouchon B., Piper K., Kolbe H., Dessein A.J. Characterisation of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humans. Mol. and Biochem. Parasitology. 84:1997;155-165.
4. Hoffman K.F., Strand M. Identification of a Schistosoma mansoni tegumental protein with similarity to cytoplasmic dynein light chains. J. Biol. Chem. 271:1996;26117-26123.
5. Dessein A.J., Begley M., Demeure C., Caillol D., Fueri J., Dos Reis M.G., Andrade Z.A., Prata A., Bina J.C. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. J. Immunol. 140:1988;2727-2736.
6. Couisinier-Paris P., Bourgois A., Dessein H., Bacelar O., Rodrigues V. Jr, Kohlstädt S., Buonavista N., Pène J., Dessein A.J. Identification of a major T cell immunogen in the anti-schistosome response of residents in an area endemic for Schistosoma mansoni. Eur. J. Immunol. 25:1995;903-910.
7. Wright M.D., Daven K.M., Mitchell G.F. The functional and immunological significance of some schistosome surface molecules. Parasitol. Today. 7:1991;56-58.
8. Argiro L., Henri S., Dessein H., Dessein A.J., Bourgois A. Induction of a protective immunity against S. mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum. Vaccine. 17:1999;13-18.
9. Tao M.-H., Levy R. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B cell lymphoma. Nature. 362:1993;755-758.
10. Smithers S.R., Terry R.J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology. 55:1965;695-700.
11. Rihet P., Demeure C.E., Dessein A.J., Bourgois A. Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area. Eur. J. Immunol. 22:1992;2063-2070.
12. Henri S., Argiro L., Dessein H., Bourgois A. Induction of protective immunity against S. mansoni in mice vaccinated with Sm10-DLC. Parasitology Int. 47:1998;261-268.
13. Burgess A.W., Camakaris J., Metcalf D. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J. Biol. Chem. 252:1977;1998-2003.
14. Morrissey P.J., Bressler L., Park L.S., Alpert A., Gillis S. Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J. Immunol. 139:1987;1113-1119.
15. Heufler C., Koch F., Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167:1988;700-705.
16. Fischer H.-G., Frosch S., Reske K., Reske-Kunz A.B. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. J. Immunol. 141:1988;3882-3888.
17. Smith P.D., Lamerson C.L., Wong H.L., Wahl L.M., Wahl S.M. Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. J. Immunol. 144:1990;3829-3834.
18. Tam J.P., Clavijo P., Lu Y.-A., Nussenzweig V., Nussenzweig R., Zavala F. Incorporation of T and B epitopes of the circumsporozoïte protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 171:1990;299-306.
19. Tarr P.E., Lin R., Mueller E.A., Kovarik J.M., Guillaume M., Jones T.C. Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine. Vaccine. 14:1996;1199-1204.
20. Bergquist N.R., Colley D.G. Schistosomiasis vaccines; research to development. Parasitol. Today. 14:1998;99-104.